Overview

Economy of Finland is highly industrialized and with the region’s substantial presence in biotechnology and life sciences sector, the Finish landscape has become the most sought after destination for medicine and medical device manufacturers for investments in the region. The Finnish Medicines Agency (FIMEA) looks after the market authorizations and registrations in the region. Though the market seems to be attractive for investments, navigating through the established Regulatory regime might pose a challenge for foreign manufacturers for successful compliance.

Freyr keeping abreast with the Finnish Regulatory market updates, assists foreign manufacturers to navigate the Regulatory regime in the region with end-to-end Regulatory Affairs and consulting services. Freyr’s end-to-end Regulatory affairs consulting for Finland span across:

  • Medical Devices
  • Pharmaceuticals / Drugs
  • Cosmetics and Food Supplements
  • Biologics

Freyr Offerings

  • Strategic Regulatory Consulting
  • Strategic business development focusing on the European market
  • Regulatory roadmap for market access
  • Regulatory Affairs & Regulatory intelligence
  • Registration pathways and license management services
  • End-to-end operational support
  • Dossier preparation, review and management
  • Regulatory Submissions
  • Market assessments
  • In-country representation 

Freyr Advantages

  • Expert Regulatory team with proven global RA expertise
  • Proactive and Collaborative approach
  • Quick turnarounds and faster time-to-market
  • Keeping abreast with region-specific legislation and Regulatory guidelines